A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma

Authors

  • C Catania Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • G Pelosi Department of Pathology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • N Fazio Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • R Biffi Division of Abdomino-Pelvic Surgery, European Institute of Oncology Ripamonti 435 Milan, Italy
  • G Spitaleri Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • C Noberasco Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • MG Zampino Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • A Maggioni Division of Gynecology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • G Trifirò Division of Nuclear Medicine, European Institute of Oncology Ripamonti 435 Milan, Italy
  • F Toffalorio Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • P Della Vigna Divison of Radiology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • F De Braud Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy
  • T De Pas Division of New Drugs Development and Clinical Pharmacology, European Institute of Oncology Ripamonti 435 Milan, Italy

DOI:

https://doi.org/10.3109/02841860903081913

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2010-01-01

How to Cite

Catania, C., Pelosi, G., Fazio, N., Biffi, R., Spitaleri, G., Noberasco, C., … Pas, T. D. (2010). A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma. Acta Oncologica, 49(1), 123–124. https://doi.org/10.3109/02841860903081913